• Educational resources
  • Events
  • Expert Panel
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v4.0 – P Expiration Date: 10/16/2027

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Bullous pemphigoid
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
  • Chronic obstructive pulmonary disease
  • IL-33
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Potential for Disease Modification in Atopic Dermatitis
Dermatology
2 min
expert video

Potential for Disease Modification in Atopic Dermatitis

Type 2 Inflammation
Dermatology
2 min
expert video

Type 2 Inflammation

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis
Dermatology
20 min
Podcast

ADVENT On Air | Exploring The Urgency to Treat in Atopic Dermatitis

Role of Type 2 Cytokines in Asthma and COPD
Type 2 Inflammation
2 min
expert video

Role of Type 2 Cytokines in Asthma and COPD

Unmet Needs in Bullous Pemphigoid
Dermatology
3 min
expert video

Unmet Needs in Bullous Pemphigoid

Diagnosis and Clinical Manifestations of Bullous Pemphigoid
Dermatology
2 min
expert video

Diagnosis and Clinical Manifestations of Bullous Pemphigoid

Pathophysiology of Bullous Pemphigoid
Dermatology
4 min
expert video

Pathophysiology of Bullous Pemphigoid

The Pathophysiology of Prurigo Nodularis
Dermatology
5 min
videoanimation

The Pathophysiology of Prurigo Nodularis

Persistence of AD From Childhood Into Adulthood
Dermatology
3 min
expert video

Persistence of AD From Childhood Into Adulthood

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch
Dermatology
4 min
expert video

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch

Key Treatment Considerations for Management of Atopic Dermatitis in Children
Dermatology
2 min
expert video

Key Treatment Considerations for Management of Atopic Dermatitis in Children

AD, PN, and CSU: Similar Inflammation, Distinct Itch
Dermatology
8 min
expert video

AD, PN, and CSU: Similar Inflammation, Distinct Itch

    1
    ...
    121314
    ...
    23